remains debatable in carnivorous fish. We aimed to evaluate and compare the response of hepatic lipogenic gene expression to dietary carbohydrate intake/glucose and dietary protein intake/amino acids (AAs) during acute stimulations using both in vivo and in vitro approaches. For the in vivo trial, three different diets and a controlledfeeding method were employed to supply fixed amount of dietary protein or carbohydrate in a single meal; for the in vitro trial, primary hepatocytes were stimulated with a low or high level of glucose (3 mM or 20 mM) and a low or high level of AAs (one-fold or four-fold concentrated AAs). In vitro data showed that a high level of AAs upregulated the expression of enzymes involved in DNL [fatty acid synthase (FAS) and ATP citrate lyase (ACLY)], lipid bioconversion [elongation of very long chain fatty acids like-5 (Elovl5), Elovl2, ⌬6 fatty acyl desaturase (D6D) and stearoyl-CoA desaturase-1 (SCD1)], NADPH production [glucose-6-phosphate dehydrogenase (G6PDH) and malic enzyme (ME)], and transcriptional factor sterol regulatory element binding protein 1-like, while a high level of glucose only elevated the expression of ME. Data in trout liver also showed that high dietary protein intake induced higher lipogenic gene expression (FAS, ACLY, and Elovl2) regardless of dietary carbohydrate intake, while high carbohydrate intake markedly suppressed the expression of acetyl-CoA carboxylase (ACC) and Elovl5. Overall, we conclude that, unlike rodents or humans, hepatic fatty acid biosynthetic gene expression in rainbow trout is more responsive to dietary protein intake/AAs than dietary carbohydrate intake/glucose during acute stimulations. This discrepancy probably represents one important physiological and metabolic difference between carnivores and omnivores. target of rapamycin; fatty acid biosynthesis; lipogenesis; protein; carbohydrate; rainbow trout DE NOVO LIPOGENESIS (DNL) is the metabolic pathway that synthesizes fatty acids from excess carbon donors; these fatty acids can then be converted into triglycerides, the major energy storage form in vertebrates (43, 83, 85) . In mammals, hepatic lipogenesis is very responsive to dietary modifications (40). Consumption of a diet rich in carbohydrates stimulates the lipogenic pathway, whereas consumption of a diet rich in lipids and poor in carbohydrates, or rich in polyunsaturated fatty acids decreases this metabolic pathway (40, 86) . A highcarbohydrate diet can induce hyperglycemia, thereby stimulating lipogenesis via several mechanisms (40). First, by being glycolytically converted to acetyl-CoA, glucose provides substrate for fatty acid synthesis. Secondly, glucose stimulates glycolytic and lipogenic gene expression (24). Finally, glucose stimulates the release of insulin from the pancreas, thereby activating insulin/Akt signaling pathway (40, 69), which stimulates hepatic lipogenesis via the transcription factor sterol regulatory element binding protein-1c (SREBP-1c) (32). Regarding dietary protein, rodent data showed that the metabolic adaptation to a high-protein diet included a downregulation of lipogenesis at both gene expression and enzymatic levels (64). Notably, the activity of lipogenic pathway also depends on the availability of cofactors, such as NADPH, produced by the pentose phosphate pathway (27), and DNL may serve as a key regulator in tandem with elongation and desaturation (10, 13, 36) .
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Whereas numerous long-term feeding studies in fish have shown that carbohydrate-rich diets elevated the expression and activities of lipogenic enzymes and/or NADPH yielding as in mammals (4, 18, 20, 26, 38, 45, 78, 79) , studies in short-term feeding, particularly in carnivorous species, clearly have unveiled a different landscape. Recent in vivo studies have demonstrated that high-carbohydrate diets/glucose failed or only had very limited effects in stimulating lipogenic gene expression/enzyme activities (30, 35, 75) . For instance, Seiliez et al. (75) reported that a diet rich in carbohydrate and low in protein failed to elevate the expression of genes related to lipogenesis (FAS, ACLY, G6PDH, and SREBP1) compared with fasted control. Jin et al. (35) also showed that intraperitoneal glucose administration only induced minor changes for the gene expression of ATP citrate lyase (ACLY), without affecting the expression of other lipogenic genes (FAS and ACLY) or the transcription factor SREBP1. Following radiolabeled 14 C 1 -glucose course, Hemre and Kahrs (30) clearly showed that hepatic lipogenesis converted only a very small proportion of injected glucose into lipids in Atlantic cod. By using metformin, a common anti-diabetic drug, Panserat et al. (55) observed that metformin effectively reduced postprandial hyperglycemia in trout fed high dietary carbohydrates, possibly through stimulating hepatic lipogenic mRNA levels and activities, indicating the poor biotransformation of glucose to fatty acids in trout. In contrast, enhanced lipogenic gene expression and/or enzymatic activities was repeatedly observed in rainbow trout and blackspot seabream when fed diets rich in protein and low in carbohydrate (23, 75) , implying that high-protein diets appear to play a predominant role in stimulating the lipogenic pathway in carnivorous fish. It is also worthy to note that most of these studies investigating high-carbohydrate effects were associated with the expense of dietary protein/lipids modifications (18, 38, 45, 75, 84, 91) ; hence, it is difficult to distinguish which nutrient induced those metabolic changes. Moreover, some studies concluded that high-carbohydrate diets/D-glucose enhanced hepatic lipogenesis mainly based on the results of NADPH yield, namely the gene expression and/or enzyme activities of G6PDH, 6PGD, or ME (20, 26, 84) , instead of de novo lipogenic gene expression or enzymatic activities. Therefore, the link between dietary carbohydrate/protein and DNL remains debatable in carnivorous fish.
The aim of the current studies was to evaluate and compare the response of hepatic lipogenic gene expression to dietary carbohydrate intake and dietary protein intake in vivo, and also compare the response to glucose and amino acids (AAs) in vitro during short-term stimulations. Rainbow trout, a relevant carnivorous fish model, which possess relatively high-dietary protein/AAs requirements, poor utilization of dietary carbohydrates, and "glucose-intolerant" phenotype (16) , was used as a current research model. To prevent the other nutrient intake changes (except dietary carbohydrate or protein intake), we employed a controlled-feeding method for in vivo studies. As our recent work demonstrated that hepatic lipogenesis requires the activation of mechanistic target of rapamycin complex 1 (mTORC1) in rainbow trout (14, 15, 42) as in mammals (9, 41, 63) , and elevated amino acid levels enhanced hepatic fatty acid biosynthetic gene expression through an mTORC1-dependent manner (15) , we also investigated the potential involvement of mTORC1 signaling pathway in the present study. Acute administration of rapamycin, a pharmacological inhibitor of mTOR, was employed to achieve an inhibition of mTORC1 and its downstream effectors, including p70 ribosomal S6 kinase 1 (S6K1), S6, and eukaryotic initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) (14 -16, 42, 74) .
MATERIALS AND METHODS

Ethics Statement
The experiments were carried out in accordance with legal frameworks, specifically those relating to the protection of animals used for scientific purposes (i. 
Experimental Diets and Feeding Method
Diets were manufactured at the INRA facility of Donzacq (France) using a twinscrew extruder (Clextral, France). Three diets, highprotein-low-carbohydrate (HPLC), high-protein-high-carbohydrate (HPHC), and low-protein-high-carbohydrate (LPHC), were formulated to contain different levels of dietary protein and carbohydrate, as shown in Table 1 . A controlled-feeding method, in which both diet compositions and feeding levels are strictly controlled for each treatment/tank, was employed to supply the fixed amount of dietary protein or carbohydrate intake as designed while the other nutrient intakes were almost equivalent (Table 1) .
Experimental and Sampling Procedure
Juvenile rainbow trout (Oncorhynchus mykiss, Walbaum 1792) were reared in the INRA experimental facilities at Donzacq (Landes, France) at a constant water temperature of 17.5 Ϯ 0.5°C, under natural photoperiod. Fish were fed a commercial trout diet (T-3P classic, Skretting, Fontaine-les-Vervins, France) during the acclimatization period. Fish (mean body mass 138.5 Ϯ 15 g) were randomly distributed into eight tanks (24 fish per 130-liter tank). Prior to the feeding trials, fish were food deprived for 72 h-the time required to ensure the complete emptying of the digestive tract. After this period, trout were sedated with benzocaine (10 mg/l) and treated with a single intraperitoneal injection of rapamycin (0.5 mg/kg) or vehicle (75% DMSO and 25% saline solution NaCl 0.9%) with 100 l/100 g body mass. Three hours after the intraperitoneal injection, three tanks per treatment (vehicle or rapamycin) were assigned with the diets, HPLC, HPHC, and LPHC, following the feeding ratios of 0.94%, 1.23%, and 0.86% body wt, respectively. Eight fish per tank were randomly sampled at 2, 8, and 24 h after the single meal. Trout were anesthetized with benzocaine (30 mg/l) and killed by a sharp blow to the head. Blood was removed from the caudal vein into heparinized syringes and centrifuged (3000 g, 5 min); the recovered plasma was immediately frozen and kept at Ϫ20°C. The stomach content of each fish was checked to confirm that the fish had effectively ingested the diet. Livers were dissected and immediately frozen in liquid nitrogen and kept at Ϫ80°C.
Primary Culture of Hepatocytes
For cell culture, trout (240 to 300 g) were obtained from the INRA experimental fish farm facilities (Donzacq, France), then maintained in tanks kept in a flow-through system at 18°C with well-aerated water under natural photoperiod conditions. Fish were fed to satiety every 2 days with a commercial diet (T-3P classic, Trouw, France). Prior to isolation of the liver cells, trout were left unfed for 72 h to empty the digestive tract and then facilitate in situ perfusion of the liver. At the time of the experiments, fish were anesthetized by placing them in water containing 60 mg/l aminobenzoic acid, and hepatocytes were isolated from three different individuals by in situ perfusion method described by Mommsen et al. (50) . Livers were excised and minced with a razor blade in modified Hanks' medium (136.9 mM NaCl, 5.4 mM KCl, 0.8 mM MgSO 4, 0.44 mM KH2PO4, 0.33 mM Na2HPO4, 5 mM NaHCO3, and 10 mM HEPES) supplemented with 1 mM EGTA. After filtration and centrifugation (120 g, 2 min), the resulting cell and antibiotic antimycotic solution (1ϫ) (Sigma) as the basic culture medium. Cell viability (Ͼ98%) was assessed using the trypan blue exclusion method (0.04% in 0.15 M NaCl), and cells were counted using a hemocytometer. The hepatocyte cell suspension was plated in a six-well Primaria culture dish (Becton Dickinson, Franklin Lakes, NJ) at a density of 3 ϫ 10 6 cells/well and incubated at 18°C. The culture medium was changed every 24 h over the 48 h of primary cell culture. Microscopic examination ensured that hepatocytes progressively reassociated throughout culture to form twodimensional aggregates, in agreement with earlier reports (22, 73) . For the first experiment involving different glucose and amino acid levels, 48-h cultured cells were stimulated with 4ϫ10
Ϫ9 mol/l of bovine insulin (Sigma) corresponding to the postprandial level of insulin (17, 51) , low or high level of glucose (3 mM, low Glu; or 20 mM, high Glu) (57, 75) , and a low or high level of amino acids [one-fold (low AA) or four-fold (high AA) concentrated amino acids]. In the second in vitro experiment, 48-h cultured hepatocytes were stimulated with glucose (3 mM), low or high level of insulin [1ϫ10 Ϫ9 mol/l, low insulin or 4ϫ10 Ϫ9 mol/l, high insulin, corresponding to the 2-wk fasted or postprandial insulin levels (51, 59)], and low or high levels of amino acids (low AA or high AA). Cells were harvested at 15 min for Western blot analysis or resuspended in TRIzol reagent (Invitrogen) 24 h after stimulation and stored at Ϫ80°C for subsequent mRNA extraction. The time intervals were chosen on the basis of the phosphorylation peaks of Akt/TOR signaling pathway or relevant metabolic gene expression peaks, respectively (data not shown).
Plasma Metabolite Analysis
Plasma glucose (Glucose RTU, BioMérieux, Marcy l'Etoile, France) levels were determined using commercial kits adapted to a microplate format, according to the recommendations of the manufacturer. Total plasma free amino acid levels were determined by the ninhydrin reaction (52) , with glycine as the standard.
Protein Extraction and Western Blot Analysis
Frozen livers (200 mg) from 2-h refed trout were homogenized on ice with an ULTRA-TURRAX homogenizer (IKA-WERKE, Staufen im Breisgau, Germany) in 2 ml of lysis buffer [150 mM NaCl, 10 mM Tris, 1 mM EGTA, 1 mM EDTA (pH 7.4), 100 mM sodium fluoride, 4 mM sodium pyrophosphate, 2 mM sodium orthovanadate, 1% Triton X-100, 0.5% NP-40-IGEPAL, and a protease inhibitor cocktail (Roche, Basel, Switzerland)]. Homogenates were centrifuged at 1500 g for 15 min at 4°C, and supernatant fractions were then centrifuged at 20,000 g at 4°C for 30 min. The resulting supernatant fractions were recovered and stored at Ϫ80°C. Protein concentrations were determined using the Bio-Rad protein assay kit (Bio-Rad Laboratories, Munich, Germany) with BSA as the standard. Lysates (10 g of total protein for TOR/S6/4E-BP1 and 20 g for S6K1) were subjected to SDS-PAGE.
For hepatocyte culture, cells were carefully washed with 2ϫ 1 ml of cold PBS. Then 300 l of cell lysis buffer were added before being stored at Ϫ80°C overnight. Then cells were scraped, collected, and lysed on ice for 30 min. Lysates were centrifuged at 12,000 g for 30 min at 4°C. The resulting supernatant fractions were recovered and stored at Ϫ80°C. Protein concentrations were measured with the Bio-Rad protein assay kit (Bio-Rad Laboratories) with BSA as the standard. Lysates (2 g of total protein per lane for S6, 7 g for S6K1, respectively) were subjected to SDS-PAGE.
All antibodies used were obtained from Cell Signaling Technologies (Ozyme, Saint Quentin Yvelines, France , and anti-␤-tubulin (no. 2146) were purchased from Cell Signaling Technologies (Ozyme). We have confirmed that all of these antibodies successfully cross-reacted with rainbow trout (14) . After washing, membranes were incubated with an IRDye infrared secondary antibody (LI-COR Biosciences, Lincoln, NE). Bands were visualized by infrared fluorescence using the Odyssey Imaging System (LI-COR Biosciences) and quantified by Odyssey infrared imaging system software (version 3.0, LI-COR Biosciences).
Gene Expression Analysis
Total RNA samples were extracted from hepatocytes using TRIzol reagent (Invitrogen), according to the manufacturer's recommendations, and were quantified by spectrophotometry (absorbance at 260 nm). The integrity of the samples was assessed using agarose gel electrophoresis. A 1-g sample of the resulting total RNA was reverse transcribed into cDNA using the SuperScript III reverse transcriptase kit (Invitrogen), and random primers (Promega, Charbonniéres, France), according to the manufacturers' instructions. Target gene expression abundance was determined by quantitative real-time (q)RT-PCR, using specific primers (35, 39, 81) . Primers targeting malic enzyme (forward: TACGTGCG-GTGTGTGTGACG; reverse: GTGCCCACATCCAGCATGAC), were newly designed using Primer3 software. To confirm specificity, amplicons were purified and sequenced (Beckman Coulter Genomics, Bishop's Stortford, Hertfordshire, UK).
qRT-PCR was carried out on a LightCycler 480 II (Roche Diagnostics, Neuilly sur Seine, France) using LightCycler 480 SYBR Green I Master (Roche Diagnostics, Mannheim, Germany). qRT-PCR analyses focused on several key enzymes of hepatic metabolism: ACLY (EC 2.3.3.8), ACC (EC 6.4.1.2), and fatty acid synthase (FAS; EC 2.3.1.85) for lipogenesis; glucose-6-phosphate dehydrogenase (G6PDH; EC 1.1.1.49) and malic enzyme (ME, EC 1.1.1.40) for pentose phosphate shunt; ⌬6 fatty acyl desaturase (D6D; EC 1.14.19.3), stearoyl-CoA desaturase-1 (SCD1 or D9D; EC 1.14.19.1), elongation of very long-chain fatty acids like-5 (Elovl5; EC 2.3.1.199) and elongation of very long chain fatty acids like-2 (Elovl2; EC 2.3.1.199) for fatty acid bioconversion, and a relevant transcription factor sterol regulatory element binding protein 1-like (SREBP1c). Elongation factor-1␣ (EF1␣) was used as a nonregulated reference gene, as previously used in rainbow trout, and it was stably expressed in our investigations (data not shown).
PCR was performed using 2 l of the diluted cDNA (76 times diluted) mixed with 0.24 l of each primer (10 M), 3 l LightCycler 480 SYBR Green I Master (Roche Diagnostics) and 0.52 l DNase/ RNase/protease-free water (5 prime, Hamburg, Germany) in a total volume of 6 l. The PCR protocol was initiated at 95°C for 10 min for initial denaturation of the cDNA and hot-start Taq-polymerase activation, followed by 45 cycles of a three-step amplification program [15 s at 95°C, 10 s at melting temperature Tm (59 -65°C), 4.8 s at 72°C], according to the primer set used. Melting curves were systematically monitored (5 s at 95°, 1 min at 65°, temperature slope at 0.11°C/s from 65 to 97°C) at the end of the last amplification cycle to confirm the specificity of the amplification reaction. Each PCR assay included quadruplicates for each sample (duplicates of reverse transcription and PCR amplification, respectively) and also negative controls (reverse transcriptase and RNA free samples). Relative quantification of target gene expression was determined using the EMethod from the LightCycler 480 software (version SW 1.5; Roche Diagnostics). PCR efficiency, assessed by the slope of a standard curve using serial dilutions of cDNA, ranged between 1.85 and 2.
Statistical Analysis
The results of postprandial plasma metabolites are expressed as means Ϯ SE (n ϭ 8). The results of Western blot analyses and gene expression are expressed as means Ϯ SE (n ϭ 6). The effects of diets, intraperitoneal administration of rapamycin or vehicle, and interaction were analyzed using two-way ANOVA in SPSS 17.0. In cases in which data were nonparametric or not homoscedastic, data transformations, such as logarithms, square roots, and reciprocals, were used to meet ANOVA criteria. Normality was assessed using the ShaprioWilk test, while homoscedasticity was determined using Levene's test. For all statistical analyses, the level of significance was set at P Ͻ 0.05.
For cell culture experiments, the results of Western blot (n ϭ 6) and gene expression (n ϭ 9) are expressed as means Ϯ SE and were analyzed using linear mixed-effects models (MIXED) procedure with fish as the subject effect (SPSS 17.0). When interaction was significant, results were further analyzed using the EMMEANS subcommand. For all statistical analyses, the level of significance was set at P Ͻ 0.05.
RESULTS
High Carbohydrate Intake Induced Hyperglycemia Irrespective of the Protein Intake
To check the effect of controlled feeding, we investigated postprandial plasma glucose and total plasma free amino acids (FAA) levels (Fig. 1) . Compared with low-carbohydrate intake treatment (HPLC), high-carbohydrate intake treatments (HPHC and LPHC) induced higher plasma glucose levels 8 and 24 h after controlled feeding, irrespective of the administration of vehicle or rapamycin, and decreased FAA levels 24 h after controlled feeding. Protein and carbohydrate intake also affected FAA levels 8 h after controlled feeding (P Ͻ 0.05), with HPLC treatment inducing higher FAA levels than LPHC treatment. Notably, rapamycin significantly decreased plasma glucose levels but elevated FAA levels 8 h after controlled feeding compared with vehicle-treated groups.
High Protein Intake Induced Enhanced mTORC1 Activation
We further investigated the effects of administration of vehicle or rapamycin and different nutrient intakes on the regulation of mTORC1 signaling pathway in trout liver (Fig.  2) . Protein phosphorylation of TOR, S6K1, S6, and 4EBP1 was markedly inhibited by rapamycin irrespective of diet. High protein intake (HPLC and HPHC) induced higher phosphorylation of TOR and 4EBP1 compared with low protein intake (LPHC), while no statistical difference was observed for the phosphorylation of S6K1 and S6. 
Rapamycin Inhibited the Expression of Hepatic Fatty Acid Biosynthetic Genes
We further measured the expression of selected enzymes involved in fatty acid biosynthesis in the liver (Fig. 3) . Compared with vehicle-treated groups, rapamycin significantly repressed the mRNA levels of FAS, ACLY, ACC, Elovl2, Elovl5, D6D, and G6PDH without affecting ME or SREBP1c. Nutrient intake significantly affected the expression of ACC and Elovl5 (Fig. 3 , C and E; P Ͻ 0.05), with high protein-low carbohydrate intake groups (HPLC) obtaining higher ACC gene expression compared with high protein-high carbohydrate intake groups (HPHC), and high carbohydrate intake (HPHC and LPHC) suppressing the expression of Elovl5 compared with low carbohydrate intake groups (HPLC). An interaction between injection and diets was recorded for Elovl2 ( Fig. 3D ; P Ͻ 0.05), showing that high protein intake (HPLC and HPHC) induced higher Elovl2 gene expression compared with low protein intake (LPHC) in vehicle-treated groups, while there were no modifications for rapamycin-treated groups. The mRNA levels of FAS, ACLY, D6D, G6PDH, ME, or SREBP1c were not affected by protein or carbohydrate intake.
High Levels of AAs Enhanced mTORC1 Activation Irrespective of Glucose Levels
To overcome the complexity in vivo, especially the metabolite exchange between organs and hormonal effects, we used cell culture approach to investigate the effects of different glucose and amino acid levels on the regulation of mTORC1 signaling pathway in trout hepatocytes (Fig. 4) . The phosphorylation of S6K1 and S6 was markedly enhanced by elevated AA levels, while no glucose effect or interaction was observed. 
High Level of AAs Predominantly Upregulated Fatty Acid Biosynthetic Gene Expression
We further investigated the effects of different glucose/AA levels on the regulation of fatty acid biosynthetic gene expression in trout hepatocytes (Fig. 5) . We observed that mRNA levels of the key enzymes involved in de novo lipogenesis (FAS and ACLY), fatty acid bioconversion (Elovl5, Elovl2, D6D, and SCD1), NADPH production (G6PDH and ME), and transcriptional factor SREBP1c were significantly upregulated by high AA levels, while glucose only increased the expression of ME. The expression of ACC in trout hepatocytes was too low to be measured.
Fatty Acid Biosynthetic Gene Expression Was Also Upregulated by Insulin Levels
Considering that high dietary protein intake in vivo can induce not only elevated plasma AA levels but also higher insulin secretion (25, 51), we further stimulated trout hepatocytes with different insulin and AA levels to determine which one is the main factor on the regulation of fatty acid biosynthetic gene expression (Fig. 6) . We observed that the mRNA levels of FAS, Elovl5, and Elovl2 were upregulated by both elevated insulin and AA levels, while the gene expression of ACLY, G6PDH, ME, D6D, and SCD1 was only upregulated by increased AA levels. No change was observed for SREBP1c in the current trial.
DISCUSSION
Protein metabolism in rainbow trout is intimately linked to hepatic glucose metabolism since protein and amino acid catabolism provides substrates that channel into gluconeogenic pathways, and excessive AAs attenuate insulin action on hepatic gluconeogenesis via an mTORC1/S6K1-induced feedback loop (15, 42) . However, our latest data have also showed that high levels of AAs promote hepatic fatty acid biosynthesis through upregulating the expression of genes related to DNL, NADPH production, and fatty acid bioconversion, and by elevating the amino acid catabolic pathway in trout hepatocytes (15) . In this study, we further evaluated and compared the capacity of dietary protein intake/AAs and dietary carbohy- Fig. 3 . Gene expression of selected enzymes involved in fatty acid biosynthesis in the liver of rainbow trout subjected to intraperitoneal administration of vehicle or rapamycin, 24 h after controlled feeding. mRNA levels of genes involved in de novo lipogenesis, including fatty acid synthase (FAS; A), ATP citrate lyase (ACLY; B), and ACC (C); fatty acid bioconversion, including Elovl2 (D), Elovl5 (E), and D6D (F); NADPH production, including G6PDH (G) and ME (H) and transcriptional factor SREBP1c (I) were measured using real-time RT-PCR. Expression values are normalized with elongation factor-1 alpha (EF1␣)-expressed transcripts. Results are expressed as means Ϯ SE (n ϭ 6) and were analyzed using two-way ANOVA (P Ͻ 0.05) followed by a Tukey multiple-comparison test.
drate intake/glucose in stimulating hepatic lipogenic gene expression in rainbow trout liver and primary hepatocytes during short-term stimulations. Unlike earlier studies in rodents, chickens, or humans (1, 2, 56, 64, 87), we provide both in vivo and in vitro evidence that hepatic fatty acid biosynthetic gene expression in rainbow trout is more responsive to dietary protein intake and AAs than dietary carbohydrate intake and glucose during acute stimulations; dietary protein intake and AAs stimulate fatty acid biosynthetic gene expression via an mTORC1-dependent manner.
High Carbohydrate Intake Induced Hyperglycemia Irrespective of the Protein Intake
High carbohydrate intake induced higher plasma glucose levels 8 and 24 h after controlled feeding and markedly decreased FAA levels 24 h after controlled feeding. These results are consistent with previous demonstrations in rainbow trout (60, 61, 75, 82) , showing that high-carbohydrate diets induced hyperglycemia and reduced plasma AA levels. These plasma parameters clearly confirmed the efficiency of controlled feeding method. However, despite these confirmations, one limit of this method still needs to be considered. With controlled feeding method, the amount of nutrient intake for each tank/treatment had been well controlled; however, whether each individual had ingested the same amount of feed was not guaranteed, which may account for the high individual variations, as observed for the phosphorylation of S6K1 and S6, and mRNA levels of FAS and ACLY in the in vivo trial.
It is worthy to note that rapamycin markedly decreased plasma glucose levels 8 h after controlled feeding and suppressed the expression of G6Pase I and G6Pase II (data not shown), in line with our previous finding showing that acute rapamycin administration reduced the hyperglycemia induced by intraperitoneal glucose injection via inhibiting hepatic gluconeogenesis at both gene expression and enzyme activity levels in rainbow trout (16) . Interestingly, rapamycin also enhanced plasma FAA levels 8 h after controlled feeding. This elevated FAA level was negatively associated with the reduced glycemia, which is consistent with previous observations in trout (60, 61, 75, 82) . Given that AAs, especially gluconeogenic AAs, can promote glucose production through hepatic gluconeogenic pathway (5, 15), we presume that both the elevated FAA levels and the reduced glycemia by rapamycin may be related to the suppressed hepatic gluconeogenesis, as previously demonstrated (16), implicating the importance of hepatic gluconeogenesis in modulating glucose homeostasis. Notably, consistent with this deduction, recent work using stable tracer method by Viegas et al. (89) revealed that supplementation of digestible starch resulted in a significant reduction of gluconeogenic contributions to systemic glucose appearance in sea bass.
High Protein Intake/AAs Levels Enhanced mTORC1 Activation Regardless of Carbohydrate Intake and Glucose Levels
mTOR is an evolutionarily conserved serine and threonine kinase that senses both nutrients and insulin signaling to control a myriad of cellular processes (80) . Here, we observed that high protein intake induced higher phosphorylation of TOR and 4EBP1 compared with low protein intake treatment regardless of dietary carbohydrate intake. Despite no statistical difference, the phosphorylation of S6K1 and S6 also showed elevated mean values in trout under high protein intake treatments compared with low protein intake treatment, similar to results for TOR and 4EBP1. In vitro data further confirmed the in vivo observations showing that a high level of AAs enhanced S6K1 and S6 phosphorylation irrespective of glucose levels. Therefore, our results suggest that high protein intake/AA levels Results are means Ϯ SE (n ϭ 6) and were analyzed using linear mixed-effects models (MIXED) procedure (P Ͻ 0.05). Glu refers to low or high glucose; AA refers to low or high level of amino acids. Glu*AA is the interaction between Glu and AA.
enhanced mTORC1 activation regardless of carbohydrate intake/glucose levels in rainbow trout. This finding is in agreement with previous in vivo findings in trout, reporting that diet rich in protein and low in carbohydrates induced higher S6 phosphorylation in liver and elevated S6K1, S6, and 4EBP1 phosphorylation in muscle compared with highcarbohydrate-low-protein diet (75) . It is also consistent with studies in rats demonstrating that high protein intake and high levels of AAs elevated the phosphorylation of mTOR and 4EBP1 compared with low protein intake and low levels of AAs (11) .
Hepatic Fatty Acid Biosynthesis Was More Responsive to Dietary Protein Intake/AAs Than Dietary Carbohydrate Intake/Glucose
In vitro data clearly showed that the expression of genes related to hepatic DNL (FAS and ACLY), fatty acid bioconversion (Elovl5, Elovl2, D6D, and SCD1), NADPH production (G6PDH and ME), and SREBP1c, a transcription factor that activates all of the genes needed to produce fatty acids and triglycerides in liver (32), were coordinately upregulated by the high level of AAs, while the high level of glucose only . mRNA levels of genes involved in de novo lipogenesis including FAS (A), and ACLY (B), transcriptional factor SREBP1c (C); NADPH production including G6PDH (D) and ME (E); and fatty acid bioconversion including Elovl5 (F), Elovl2 (G), D6D (H), and SCD1 (I) in the primary hepatocytes of rainbow trout were measured 24 h after the stimulations. Expression values are normalized with elongation factor-1 alpha (EF1␣)-expressed transcripts. Results are means Ϯ SE (n ϭ 9) and were analyzed using linear mixed-effects models (MIXED) procedure (P Ͻ 0.05).
elevated the expression of ME, indicating that in rainbow trout hepatocytes, fatty acid biosynthetic gene expression is more responsive to AAs than glucose. In line with these observations, in vivo data also showed that high protein intake induced higher Elovl2 gene expression regardless of carbohydrate intake, while high carbohydrate intake suppressed the expression of ACC and Elovl5. Notably, despite the absence of statistical significance for the expression of FAS, ACLY, and D6D by nutrient intake, they exhibited higher mean mRNA levels in high-protein intake groups. Therefore, we conclude that hepatic fatty acid biosynthetic gene expression in rainbow trout is more responsive to dietary protein intake/AAs than dietary carbohydrate intake/glucose during acute stimulations. The finding that dietary protein/AAs is a more potent stimulator for hepatic fatty acid biosynthesis compared with dietary carbohydrate/glucose is in agreement with previous in vitro observations demonstrating that increased AA levels upregulated fatty acid biosynthetic gene expression in trout Ϫ9 mol/l (low insulin) or 4 ϫ 10 Ϫ9 mol/l (high insulin)] and a low or high level of amino acids (low AA or high AA, one-fold or four-fold concentrated AAs). mRNA levels of genes involved in de novo lipogenesis including FAS (A) and ACLY (B), transcriptional factor SREBP1c (C); NADPH production including G6PDH (D) and ME (E); and fatty acid bioconversion, including Elovl5 (F), Elovl2 (G), D6D (H), and SCD1 (I) in the primary hepatocytes of rainbow trout were measured 24 h after the stimulations. Expression values are normalized with elongation factor-1 alpha (EF1␣)-expressed transcripts. Results are expressed as means Ϯ SE. (n ϭ 9) and were analyzed using linear mixed-effects models (MIXED) procedure (P Ͻ 0.05). When interaction was significant, results were further analyzed using the EMMEANS subcommand. Ins refers to low or high Insulin; AA refers to a low or high level of amino acids. Ins*AA denotes interaction between Ins and AA. (15) and in vivo observations reporting that high-proteinlow-carbohydrate diets stimulated lipogenic gene expression (FAS and SREBP1) and enzyme activity (FAS, G6PDH, and ME) compared with low-protein-high-carbohydrate diets in rainbow trout and blackspot seabream, respectively (23, 75) . However, these results are different from the demonstrations in rodents, chickens, or humans reporting that high-protein (HP) diets induce downregulations of fatty acid biosynthesis in liver at both gene expression and enzymatic levels (1, 2, 7, 56, 64, 67, 87, 90) . Data from mice have shown that an increased flux of AAs reaching the hepatoportal area in HP diet conditions promotes AA catabolism and acetyl-CoA synthesis; however, it was suggested that the synthesized acetyl-CoA is either channeled into the TCA cycle or used for ␤-hydroxybutyrate production, but not converted to fatty acids through unknown reasons (64, 72, 92) . Therefore, DNL rates might be lower or even absent after an HP diet (72) . On the basis of our results, we reason that, unlike rodents or humans, protein and AAs are more potent in stimulating hepatic lipogenesis compared with carbohydrate and glucose in rainbow trout, confirming the hypothesis of Tocher (85), who suggested that AAs are the preferred carbon source for lipogenesis in trout. Future work with tracer method is needed to further confirm this conclusion at nutrient flux level. It is of interest to note that current observations in rainbow trout are similar to those in the domestic cat, a terrestrial carnivorous animal, in which acetate is the predominant carbon source for DNL in both liver and adipose tissue instead of glucose, which is the major substrate for DNL in humans and rodents (3a, 62, 88) . However, unlike trout, in humans and rodents, liver is the primary site for DNL (6, 29, 85) , while in cats, adipose tissue serves this function, followed by liver, mammary glands, and muscle (3a, 88) .
The results that high carbohydrate intake and glucose failed to stimulate hepatic lipogenic gene expression but upregulated ME (in vitro) are consistent with previous studies reporting that high-carbohydrate diets and glucose failed or only had limited effects in stimulating lipogenic gene expression and enzyme activities in rainbow trout (30, 35, 75) . Notably, similar demonstrations were reported in cat and mink (68, 88) , showing that fatty acids are not synthesized from glucose, probably due to the absence of glucokinase in feline liver (48, 71) . The results also confirmed the presumption of Hemre et al. (31) that carbohydrate is needed to stimulate lipid biosynthesis, not so much through delivery of carbon backbones, but rather via increased availability of cytosolic reducing equivalents and are consistent with some other demonstrations in carnivorous fish (4, 20, 26, 84) . However, this is different from what has been shown in mammals, with a diet high in simple carbohydrates. Such a diet leads to elevated expression of enzymes involved in DNL, MUFA synthesis (SCD1), and PUFA synthesis (Elovl2, Elovl5, and D6D) (10, 27, 36, 40, 86) . The poor induction of hepatic lipogenic and fatty acid biosynthetic gene expression to dietary carbohydrate intake and glucose could be one of the contributors to the poor dietary carbohydrate utilization in rainbow trout. As trout represent a relevant carnivorous model (54, 71), we presume this demonstration may be applicable for general carnivores, including piscivorous fish and terrestrial carnivores.
Dietary Protein and AAs Stimulate Fatty Acid Biosynthesis in an mTORC1-Dependent Manner
In vitro data showed that elevated fatty acid biosynthetic gene expression by a high level of AAs was associated with the enhanced phosphorylation of S6K1 and S6, which is totally consistent with our previous investigation (15) . Furthermore, we also reported that elevated fatty acid biosynthetic gene expression was markedly suppressed by mTORC1 inhibition (15) . In vivo data showed that high protein intake not only induced higher TOR and 4EBP1 phosphorylation but also induced higher Elovl2 gene expression regardless of carbohydrate intake. Although not statistically significant, the expression of FAS, ACLY, and D6D exhibited similar patterns as the phosphorylation of S6K1 and S6, showing that high protein intake induced higher mean mRNA levels. Moreover, mTORC1 inhibition suppressed the expression of FAS, ACLY, ACC, Elovl2, Elovl5, D6D, and G6PDH, indicating that the regulation of hepatic fatty acid biosynthetic gene expression is mTORC1 dependent, which is consistent with our latest in vitro demonstrations in trout (15) . Therefore, our data clearly demonstrate that dietary protein intake and AAs stimulate fatty acid biosynthetic gene expression through an mTORC1-dependent manner. Consistent with this observation, recent investigation in zebrafish also has shown that mTORC1 activation is required for hepatic lipid accumulation, as rapamycin reverses hepatic lipid accumulation and associated gene expression changes (lipogenic, inflammatory, oxidative stress, and ER stress genes) (70) .
Indeed, the regulation of fatty acid biosynthesis, especially the regulation of lipogenesis is very complex. Mammalian studies have demonstrated that several cellular signaling pathways, including insulin/mTOR (63), AMPK (44), autophagy (94), p38MAPK (93) , amino acid response (28) , and transcription factors, including peroxisome proliferator-activated receptor ␥, liver ϫ receptor (LXR) (44) , carbohydrate responsive element-binding protein (24) , SREBP1c (34, 77) , X-box binding protein 1 (43), nuclear sterol-activated receptor LXR, and FXR (8), as well as microRNA (miRNAs) (19, 21) , are involved in the regulation of hepatic lipogenesis. Thus, we assume that mTORC1 signaling pathway is probably not the only signaling pathway that is involved in the nutrient-mediated control of fatty acid biosynthesis in rainbow trout. Future studies are merited to verify the potential involvement of other signaling pathways or transcription factors in fish.
Dietary Protein Intake Stimulated Hepatic Fatty Acid Biosynthesis Probably Mainly Through AAs Themselves Rather than Insulin
It is well known that, compared with carbohydrates, AAs are more potent insulin secretagogues in most fish species (51) . Therefore, one potential explanation for the elevated lipogenic gene expression in high dietary protein diet conditions can be due to the higher insulin secretion induced by the HP diets, as insulin has been proven a potent mediator for stimulating mTOR signaling and anabolic pathways, including glycolysis and lipid synthesis (15, 57, 69) . Given that currently the method for precisely measuring trout plasma insulin concen-tration is no longer available (58), we tested this hypothesis in vitro. Using trout primary hepatocytes, we observed that increased insulin levels markedly upregulated the gene expression of FAS, Elovl5, and Elovl2, while increased AA levels significantly upregulated the expression of enzymes involved in DNL (FAS and ACLY), lipid bioconversion (Elovl5, Elovl2, D6D, and SCD1), and NADPH production (G6PDH and ME). The results that insulin stimulated the expression of FAS, Elovl5, and Elovl2 are consistent with our previous in vitro demonstrations (15) and also in agreement with data from a previous study showing that the addition of insulin elevated FAS gene expression (42) . Regarding the effect of AAs, it is totally consistent with our previous in vitro observations (15) . Therefore, we propose that dietary protein intake stimulates hepatic fatty acid biosynthesis mainly through AAs themselves; HP diet and a high level of AAs induced release of insulin, which may also contribute to the elevated lipogenic gene expression; however, its stimulation effect is less potent compared with AAs themselves.
In summary, we provided both in vivo and in vitro evidence to demonstrate that hepatic fatty acid biosynthetic gene expression in rainbow trout is more responsive to dietary protein intake and AAs than dietary carbohydrate intake/glucose during acute stimulations; dietary protein intake and AAs stimulate fatty acid biosynthetic gene expression via an mTORC1-dependent manner. We also propose that dietary protein intake stimulates hepatic fatty acid biosynthetic gene expression mainly through AAs themselves instead of stimulating the release of insulin.
Perspectives and Significance
Unlike rodents, chickens, or humans (1, 2, 56, 64, 87), we demonstrated that hepatic fatty acid biosynthesis is more responsive to protein than carbohydrate in rainbow trout. This demonstration is supported by previous investigations or presumptions in fish (23, 31, 54, 75, 85) , and similar findings in cat and mink (68, 88) . Thus, the feature we revealed here probably represents one important physiological and metabolic difference between carnivores and omnivores. In human and other mammalian species, consumption of high dietary protein can induce hyper-TOR activation, which may, in turn, induce suppressed autophagy, thereby promoting endoplasmic reticulum (ER) stress and, chronically, causing mitochondrial dysfunction and insulin resistance (3, 46, 76, 94) . Furthermore, high dietary protein stimulates insulin hypersecretion and overactivation of mTORC1 that can blunt insulin sensitivity via mTORC1/S6K1-induced negative feedback loop, which will further increase demand of insulin secretion. The increased demand for insulin biosynthesis, in turn, increases demand in the ER, gradually leading to ER stress, increased protein misfolding, activation of unfolded protein response (UPR), and dysregulated mitochondria function. Collectively, these adverse events may eventually cause insulin resistance (12, 33, 37, 47, 65, 76, 94) . Considering that rainbow trout possess high dietary protein consumption and that acute stimulation with excessive AAs induces overactivation of mTORC1, which, in turn, attenuates insulin-mediated repression of gluconeogenesis via mTORC1/S6K1-induced negative feedback loop (15), we presume that the poor carbohydrate utilization in rainbow trout is possibly due to a combination of mitochondrial dysfunction, ER stress, hypo-autophagy, accumulation of misfolded proteins, and altered UPR as in mammals (53, 95) . Interestingly, in line with this presumption, recent investigation in zebrafish reported that fructose treatment of larval zebrafish induced hepatic lipid accumulation, which was associated with mTORC1 activation, inflammation, and oxidative stress (70) . Therefore, future work is needed to investigate the parameters related to inflammatory stresses and mitochondrial functions, as they may account for the low utilization efficiency of dietary carbohydrate/glucose and poorly inhibited hepatic gluconeogenesis in rainbow trout as in mammals. Notably, recent work by Marandel et al. (49) concluded that maintenance of ohnologous g6pcb2 pair and futile glucose/glucose-6-phosphate cycling may contribute in a significant way to the glucoseintolerant phenotype of trout and may partially explain its poor use of dietary carbohydrates. To some extent, these two limitations are consistent with each other and may coordinately exist in rainbow trout. Furthermore, as we reason that protein and AAs are more potent in the stimulation of DNL than carbohydrate or glucose in rainbow trout and AAs are probably used as substrates for DNL, future work using the tracer method is needed to measure the true contributions of AAs and AA catabolism to fat synthesis at the nutrient flux level.
